News PURE Bioscience, Inc.

Equities

PURE

US74621T2096

Market Closed - OTC Markets Other stock markets 01:50:47 2024-05-16 pm EDT			5-day change	1st Jan Change
0.085 ^USD	-4.76%		+14.86%	-34.46%

May. 06	PURE Bioscience Appoints Darin Zehr to Board of Directors	CI
Mar. 22	PURE Bioscience, Inc. announced that it has received $3 million in funding	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PURE Bioscience Appoints Darin Zehr to Board of Directors	May. 06	BU
PURE Bioscience Appoints Darin Zehr to Board of Directors	May. 06	CI
PURE Bioscience, Inc. announced that it has received $3 million in funding	Mar. 21	CI
PURE Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	Mar. 18	CI
PURE Bioscience Reports Fiscal Second Quarter 2024 Financial Results	Mar. 18	BU
PURE Bioscience, Inc. Reports Earnings Results for the First Quarter Ended October 31, 2023	Dec. 14	CI
PURE Bioscience Reports Fiscal First Quarter 2024 Financial Results	Dec. 14	BU
PURE Bioscience, Inc. Reports Earnings Results for the Full Year Ended July 31, 2023	23-10-30	CI
PURE Bioscience Reports Fiscal 2023 Financial Results	23-10-30	BU
PURE Bioscience to unveil “PURE Genius” Food Safety Program at the Annual International Association for Food Protection Meeting	23-07-05	BU
PURE Bioscience, Inc. announced that it has received $1.8 million in funding	23-07-02	CI
PURE Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	23-06-14	CI
PURE Bioscience Reports Fiscal 2023 Third Quarter And Nine-Month Financial Results	23-06-14	BU
PURE BIOSCIENCE, INC. : Change in Directors or Principal Officers (form 8-K)	23-03-21	AQ
Pure Bioscience, Inc. Announces CEO Changes	23-03-21	CI
Pure Bioscience, Inc. Announces Management Changes	23-03-21	CI
PURE Bioscience Reports Fiscal 2023 Second Quarter And Six-Month Financial Results	23-03-20	AQ
PURE BIOSCIENCE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	23-03-17	AQ
PURE Bioscience Reports Fiscal 2023 Second Quarter And Six-Month Financial Results	23-03-17	BU
PURE BIOSCIENCE, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	23-02-10	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News PURE Bioscience, Inc.

Equities

PURE

US74621T2096

Summary

Filters